Breast cancer is the second most common cancer in the world. There were about 1.7 million new cancer cases diagnosed in 2012. Its early detection is essential for reducing the rate of mortality. Yet, today’s diagnosis tools such as mammography systems, tomosynthesis systems or MRI are limited in image quality or are expensive. GratXRay, a new company found at Switzerland Innovation Park innovaare recently, aims to fill the technological gap with its novel grating interferometry breast computed-tomography system. Not only it will allow for obtaining better images and reduce the number of false positives but also significantly improve patient’s comfort during the procedure.